Deanna Wright
Gynecology · Tahlequah, OKNPI 1144321456
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Novo Nordisk at 54.3% of the total. Reporting peaked in 2023 at $526 and has fallen 76.1% since, to $125 in 2025.
Across 90 payments — averaging $15.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$756
- Amgen$134
- AstraZeneca$90
- Lilly USA, LLC$75
- GSK$67
- AbbVie$49
- plus $220 from 12 others
What the payments were for
- Food & beverage$1,38199%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 56 | $756 |
| Amgen(2 entities) | 2 | $134 |
| AstraZeneca | 6 | $90 |
| Lilly USA, LLC | 5 | $75 |
| GSK | 5 | $67 |
| AbbVie | 3 | $49 |
| Antares Pharma, Inc. | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Merck | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Lundbeck LLC | 1 | $11 |
| Organon | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few gynecology providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 74 | $93,202 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 43 | $43,243 |
| RybelsusSemaglutide | 23 | $42,890 |
| EliquisApixaban | 33 | $41,810 |
| TrulicityDulaglutide | 28 | $35,959 |
| MyrbetriqMirabegron | 30 | $30,296 |
| GemtesaVibegron | 24 | $18,235 |
| LinzessLinaclotide | 13 | $16,559 |
| BelsomraSuvorexant | 13 | $5,691 |
| Estradiol | 101 | $5,618 |
| Estradiol (Twice Weekly)Estradiol | 20 | $2,182 |
| Omeprazole | 49 | $2,085 |
| Risedronate Sodium | 12 | $1,317 |
| Montelukast Sodium | 31 | $1,237 |
| Levothyroxine Sodium | 120 | $1,227 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $756 | $136,09297 claims |
| GSKTrelegy Ellipta | $67 | $43,24343 claims |
| Lilly USA, LLCTrulicity | $75 | $35,95928 claims |
| Astellas Pharma US IncMyrbetriq | $22 | $30,29630 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $20 | $18,23524 claims |
| AbbVieLinzess | $49 | $16,55913 claims |
| MerckBelsomra | $15 | $5,69113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few gynecology providers in Oklahomaon file to place this against a meaningful peer group, so we don't.
Other gynecology in Tahlequah
- Corey BabbTulsa$169K
- Kerri AnthonyOklahoma City$5K
- Natalie JohnsonLawton$779
- Dennis SandlerOklahoma City$658
- Royice EverettOklahoma City$332
- Pablo PinzonOklahoma City$198
- Franklin BarnettMidwest City$104
- Michelle McElroyJenks$30
- Richard PolkTulsa$21
- Rebecca DeatonTulsa$16
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.